OverviewSuggest Edit

Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy. Its mission is to improve freedom and independence for oxygen therapy patients through innovative products and services. The Company's compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. As a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy, Inogen is ideally suited to develop products tailored to oxygen therapy users and to provide superior service to those users in their homes. 

TypePublic
Founded2001
HQGoleta, US
Websiteinogen.com
Employee Ratings2.8

Latest Updates

Employees (est.) (Sep 2017)602
Job Openings59
Revenue (FY, 2018)$358.1 M(+44%)
Share Price (Mar 2019)$95.1 (-1%)

Key People/Management at Inogen

Raymond Huggenberger

Raymond Huggenberger

Member of the Board of Directors

Inogen Office Locations

Inogen has offices in Goleta, San Antonio, Cleveland, Riverside and in 13 other locations
Goleta, US (HQ)
326 Bollay Dr
Aurora, US
Aurora, CO, USA
Austin, US
Austin, TX, USA
Cleveland, US
Cleveland, OH, USA
Dallas, US
Dallas, TX, USA
Denver, US
Denver, CO, USA
Show all (17)
Report incorrect company information

Inogen Financials and Metrics

Inogen Revenue

Embed Graph
View revenue for all periods
Inogen's revenue was reported to be $358.11 m in FY, 2018
USD

Revenue (FY, 2018)

358.1m

Gross profit (FY, 2018)

178.6m

Gross profit margin (FY, 2018), %

49.9%

Net income (FY, 2018)

51.8m

EBIT (FY, 2018)

37.9m

Market capitalization (15-Mar-2019)

2.1b

Closing stock price (15-Mar-2019)

95.1

Cash (31-Dec-2018)

196.6m
Inogen's current market capitalization is $2.1 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

112.5m159.0m202.8m249.4m358.1m

Revenue growth, %

41%28%

Cost of goods sold

57.0m82.7m105.5m128.2m179.5m

Gross profit

55.5m76.3m97.3m121.2m178.6m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

23.6m30.4m29.4m33.8m44.0m40.8m43.0m54.6m54.4m52.5m64.1m69.0m79.1m97.2m95.3m

Cost of goods sold

11.7m15.3m14.7m17.7m23.2m21.4m21.7m28.4m29.3m26.8m32.6m35.9m41.3m48.8m46.5m

Gross profit

11.9m15.1m14.6m16.0m20.8m19.4m21.3m26.2m25.1m25.7m31.6m33.2m37.7m48.5m48.8m

Gross profit Margin, %

51%50%50%47%47%48%49%48%46%49%49%48%48%50%51%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

56.8m66.1m92.9m143.0m196.6m

Accounts Receivable

30.8m31.4m37.0m

Inventories

1.1m870.0k1.7m18.8m27.1m

Current Assets

92.5m114.8m161.5m228.5m314.6m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

59.6m69.0m56.2m61.1m51.8m55.1m72.4m84.5m86.0m105.1m114.7m129.7m154.3m166.3m176.3m

Accounts Receivable

23.7m27.8m29.7m30.9m34.8m34.7m35.1m37.5m34.3m

Inventories

10.3m12.5m16.5m14.0m15.9m16.9m23.0m27.4m30.6m

Current Assets

87.5m97.7m89.3m100.5m109.4m114.4m124.0m142.6m158.1m176.5m198.8m219.8m251.1m283.0m299.6m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

6.8m11.6m20.5m21.0m51.8m

Depreciation and Amortization

12.1m14.0m13.6m12.3m11.3m

Inventories

(3.6m)(2.6m)(7.5m)(5.9m)(10.0m)

Accounts Payable

3.6m1.6m(86.0k)7.4m6.4m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

888.0k3.2m5.3m1.6m5.0m7.7m2.4m7.5m11.0m5.9m14.3m21.6m10.8m25.4m41.8m

Depreciation and Amortization

2.7m5.6m8.8m3.4m6.9m10.5m3.4m6.9m10.3m3.2m6.3m9.3m3.0m5.8m8.5m

Inventories

(429.0k)(1.9m)(3.2m)(199.0k)(1.8m)(3.2m)(2.2m)(5.0m)(9.2m)49.0k(2.2m)(3.5m)(4.3m)(9.1m)(12.8m)

Accounts Payable

1.2m3.1m2.0m3.0m5.9m3.0m4.3m6.4m7.8m4.0m8.5m9.1m3.9m10.8m6.2m
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Inogen Online and Social Media Presence

Embed Graph
Report incorrect company information

Inogen News and Updates

INOGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inogen, Inc. - INGN

NEW ORLEANS, March 15, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 6, 2019 to file lead plaintiff applications in a securities class action lawsuit against...

Investor Alert: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Inogen, Inc. - INGN

NEW YORK, March 7, 2019 /PRNewswire/ -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Inogen, Inc. ("Inogen" or the "Company") (NASDAQ: INGN) between November 8, 2017 and February 26,...

Faruqi & Faruqi, LLP is Investigating Inogen, Inc. (INGN) on Behalf of its Shareholders

NEW YORK, Feb. 22, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Inogen, Inc. ("Inogen" or the "Company") (NASDAQ:INGN). The investigation focuses on whether the Company's Board of Directors and/or its officers...

Former California Deputy Attorney General and Special Counsel with Johnson Fistel Launches Investigation into Inogen (INGN); Investors Suffering Losses Encouraged to Contact Firm

SAN DIEGO, Feb. 12, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Counsel, Tiffany Johnson, Esq., is investigating potential claims against Inogen, Inc. ("Inogen") (NASDAQ: INGN) for...

Muddy Waters’ Carson Block takes aim at medical devices company Inogen

Muddy Waters LLC, the renowned research firm run by short seller Carson Block, took aim at medical devices company Inogen Inc. on Friday, saying in a new report that the company's true total addressable market is much smaller than what it has been claiming and accusing management of misleading inves…

Short seller Carson Block targets medical device company Inogen

Prominent short seller Carson Block is saying that medical device company Inogen Inc has inflated the size of its markets and expects the stock price to fall.
Show more
Report incorrect company information

Inogen Frequently Asked Questions

  • When was Inogen founded?

    Inogen was founded in 2001.

  • Who are Inogen key executives?

    Inogen's key executives are Raymond Huggenberger.

  • How many employees does Inogen have?

    Inogen has 602 employees.

  • What is Inogen revenue?

    Latest Inogen annual revenue is $358.1 m.

  • What is Inogen revenue per employee?

    Latest Inogen revenue per employee is $594.9 k.

  • Who are Inogen competitors?

    Competitors of Inogen include Sagent Pharmaceuticals, Zimmer Biomet and Globus Medical.

  • Where is Inogen headquarters?

    Inogen headquarters is located at 326 Bollay Dr, Goleta.

  • Where are Inogen offices?

    Inogen has offices in Goleta, San Antonio, Cleveland, Riverside and in 13 other locations.

  • How many offices does Inogen have?

    Inogen has 17 offices.